Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer.
Emmings E, Mullany S, Chang Z, Landen CN Jr, Linder S, Bazzaro M. Emmings E, et al. Int J Mol Sci. 2019 Jan 8;20(1):229. doi: 10.3390/ijms20010229. Int J Mol Sci. 2019. PMID: 30626133 Free PMC article. Review.
UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells.
Mooneyham A, Iizuka Y, Yang Q, Coombes C, McClellan M, Shridhar V, Emmings E, Shetty M, Chen L, Ai T, Meints J, Lee MK, Gardner M, Bazzaro M. Mooneyham A, et al. Among authors: emmings e. Mol Cancer Res. 2019 Feb;17(2):370-383. doi: 10.1158/1541-7786.MCR-18-0670. Epub 2018 Oct 15. Mol Cancer Res. 2019. PMID: 30322860 Free PMC article.
RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment.
Hellweg R, Mooneyham A, Chang Z, Shetty M, Emmings E, Iizuka Y, Clark C, Starr T, Abrahante JH, Sch├╝tz F, Konecny G, Argenta P, Bazzaro M. Hellweg R, et al. Among authors: emmings e. Horm Cancer. 2018 Oct;9(5):326-337. doi: 10.1007/s12672-018-0337-6. Epub 2018 Jun 27. Horm Cancer. 2018. PMID: 29951943
Feedback